Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein

Denicar Lina Nascimento Fabris Maeda, Milene Tavares Batista, Lennon Ramos Pereira, Mariana de Jesus Cintra, Jaime Henrique Amorim, Camila Mathias-Santos, Sara Araújo Pereira, Silvia Beatriz Boscardin, Sandriana dos Ramos Silva, Eliana L. Faquim-Mauro, Vanessa Barbosa Silveira, Danielle Bruna Leal Oliveira, Stephen Johnston, Luís Carlos de Souza Ferreira, Juliana Falcão Rodrigues

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli display adjuvant effects to coadministered antigens, leading to enhanced production of serum antibodies. Despite extensive knowledge of the adjuvant properties of LT derivatives, including in vitro-generated non-toxic mutant forms, little is known about the capacity of these adjuvants to modulate the epitope specificity of antibodies directed against antigens. This study characterizes the role of LT and its non-toxic B subunit (LTB) in the modulation of antibody responses to a coadministered antigen, the dengue virus (DENV) envelope glycoprotein domain III (EDIII), which binds to surface receptors and mediates virus entry into host cells. In contrast to non-adjuvanted or alum-adjuvanted formulations, antibodies induced in mice immunized with LT or LTB showed enhanced virus-neutralization effects that were not ascribed to a subclass shift or antigen affinity. Nonetheless, immunosignature analyses revealed that purified LT-adjuvanted EDIII-specific antibodies display distinct epitope-binding patterns with regard to antibodies raised in mice immunized with EDIII or the alum-adjuvanted vaccine. Notably, the analyses led to the identification of a specific EDIII epitope located in the EF to FG loop, which is involved in the entry of DENV into eukaryotic cells. The present results demonstrate that LT and LTB modulate the epitope specificity of antibodies generated after immunization with coadministered antigens that, in the case of EDIII, was associated with the induction of neutralizing antibody responses. These results open perspectives for the more rational development of vaccines with enhanced protective effects against DENV infections.

Original languageEnglish (US)
Article number1175
JournalFrontiers in Immunology
Volume8
Issue numberSEP
DOIs
StatePublished - Sep 25 2017

Fingerprint

Viral Envelope Proteins
Dengue Virus
Neutralizing Antibodies
Epitopes
Glycoproteins
Antigens
Antibody Formation
Antibody Specificity
Antibodies
Vaccines
Enterotoxigenic Escherichia coli
Virus Internalization
Eukaryotic Cells
Virus Diseases
Immunization
Hot Temperature
Viruses
Serum

Keywords

  • Adjuvants
  • Antibodies
  • Dengue virus
  • Envelope protein
  • Heat-labile toxins
  • Immunosignature
  • Labile toxins
  • Vaccines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Maeda, D. L. N. F., Batista, M. T., Pereira, L. R., de Jesus Cintra, M., Amorim, J. H., Mathias-Santos, C., ... Rodrigues, J. F. (2017). Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein. Frontiers in Immunology, 8(SEP), [1175]. https://doi.org/10.3389/fimmu.2017.01175

Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein. / Maeda, Denicar Lina Nascimento Fabris; Batista, Milene Tavares; Pereira, Lennon Ramos; de Jesus Cintra, Mariana; Amorim, Jaime Henrique; Mathias-Santos, Camila; Pereira, Sara Araújo; Boscardin, Silvia Beatriz; dos Ramos Silva, Sandriana; Faquim-Mauro, Eliana L.; Silveira, Vanessa Barbosa; Oliveira, Danielle Bruna Leal; Johnston, Stephen; de Souza Ferreira, Luís Carlos; Rodrigues, Juliana Falcão.

In: Frontiers in Immunology, Vol. 8, No. SEP, 1175, 25.09.2017.

Research output: Contribution to journalArticle

Maeda, DLNF, Batista, MT, Pereira, LR, de Jesus Cintra, M, Amorim, JH, Mathias-Santos, C, Pereira, SA, Boscardin, SB, dos Ramos Silva, S, Faquim-Mauro, EL, Silveira, VB, Oliveira, DBL, Johnston, S, de Souza Ferreira, LC & Rodrigues, JF 2017, 'Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein', Frontiers in Immunology, vol. 8, no. SEP, 1175. https://doi.org/10.3389/fimmu.2017.01175
Maeda, Denicar Lina Nascimento Fabris ; Batista, Milene Tavares ; Pereira, Lennon Ramos ; de Jesus Cintra, Mariana ; Amorim, Jaime Henrique ; Mathias-Santos, Camila ; Pereira, Sara Araújo ; Boscardin, Silvia Beatriz ; dos Ramos Silva, Sandriana ; Faquim-Mauro, Eliana L. ; Silveira, Vanessa Barbosa ; Oliveira, Danielle Bruna Leal ; Johnston, Stephen ; de Souza Ferreira, Luís Carlos ; Rodrigues, Juliana Falcão. / Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein. In: Frontiers in Immunology. 2017 ; Vol. 8, No. SEP.
@article{20cd1ca91e454b03bdaf9bfd6e793b36,
title = "Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein",
abstract = "The heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli display adjuvant effects to coadministered antigens, leading to enhanced production of serum antibodies. Despite extensive knowledge of the adjuvant properties of LT derivatives, including in vitro-generated non-toxic mutant forms, little is known about the capacity of these adjuvants to modulate the epitope specificity of antibodies directed against antigens. This study characterizes the role of LT and its non-toxic B subunit (LTB) in the modulation of antibody responses to a coadministered antigen, the dengue virus (DENV) envelope glycoprotein domain III (EDIII), which binds to surface receptors and mediates virus entry into host cells. In contrast to non-adjuvanted or alum-adjuvanted formulations, antibodies induced in mice immunized with LT or LTB showed enhanced virus-neutralization effects that were not ascribed to a subclass shift or antigen affinity. Nonetheless, immunosignature analyses revealed that purified LT-adjuvanted EDIII-specific antibodies display distinct epitope-binding patterns with regard to antibodies raised in mice immunized with EDIII or the alum-adjuvanted vaccine. Notably, the analyses led to the identification of a specific EDIII epitope located in the EF to FG loop, which is involved in the entry of DENV into eukaryotic cells. The present results demonstrate that LT and LTB modulate the epitope specificity of antibodies generated after immunization with coadministered antigens that, in the case of EDIII, was associated with the induction of neutralizing antibody responses. These results open perspectives for the more rational development of vaccines with enhanced protective effects against DENV infections.",
keywords = "Adjuvants, Antibodies, Dengue virus, Envelope protein, Heat-labile toxins, Immunosignature, Labile toxins, Vaccines",
author = "Maeda, {Denicar Lina Nascimento Fabris} and Batista, {Milene Tavares} and Pereira, {Lennon Ramos} and {de Jesus Cintra}, Mariana and Amorim, {Jaime Henrique} and Camila Mathias-Santos and Pereira, {Sara Ara{\'u}jo} and Boscardin, {Silvia Beatriz} and {dos Ramos Silva}, Sandriana and Faquim-Mauro, {Eliana L.} and Silveira, {Vanessa Barbosa} and Oliveira, {Danielle Bruna Leal} and Stephen Johnston and {de Souza Ferreira}, {Lu{\'i}s Carlos} and Rodrigues, {Juliana Falc{\~a}o}",
year = "2017",
month = "9",
day = "25",
doi = "10.3389/fimmu.2017.01175",
language = "English (US)",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein

AU - Maeda, Denicar Lina Nascimento Fabris

AU - Batista, Milene Tavares

AU - Pereira, Lennon Ramos

AU - de Jesus Cintra, Mariana

AU - Amorim, Jaime Henrique

AU - Mathias-Santos, Camila

AU - Pereira, Sara Araújo

AU - Boscardin, Silvia Beatriz

AU - dos Ramos Silva, Sandriana

AU - Faquim-Mauro, Eliana L.

AU - Silveira, Vanessa Barbosa

AU - Oliveira, Danielle Bruna Leal

AU - Johnston, Stephen

AU - de Souza Ferreira, Luís Carlos

AU - Rodrigues, Juliana Falcão

PY - 2017/9/25

Y1 - 2017/9/25

N2 - The heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli display adjuvant effects to coadministered antigens, leading to enhanced production of serum antibodies. Despite extensive knowledge of the adjuvant properties of LT derivatives, including in vitro-generated non-toxic mutant forms, little is known about the capacity of these adjuvants to modulate the epitope specificity of antibodies directed against antigens. This study characterizes the role of LT and its non-toxic B subunit (LTB) in the modulation of antibody responses to a coadministered antigen, the dengue virus (DENV) envelope glycoprotein domain III (EDIII), which binds to surface receptors and mediates virus entry into host cells. In contrast to non-adjuvanted or alum-adjuvanted formulations, antibodies induced in mice immunized with LT or LTB showed enhanced virus-neutralization effects that were not ascribed to a subclass shift or antigen affinity. Nonetheless, immunosignature analyses revealed that purified LT-adjuvanted EDIII-specific antibodies display distinct epitope-binding patterns with regard to antibodies raised in mice immunized with EDIII or the alum-adjuvanted vaccine. Notably, the analyses led to the identification of a specific EDIII epitope located in the EF to FG loop, which is involved in the entry of DENV into eukaryotic cells. The present results demonstrate that LT and LTB modulate the epitope specificity of antibodies generated after immunization with coadministered antigens that, in the case of EDIII, was associated with the induction of neutralizing antibody responses. These results open perspectives for the more rational development of vaccines with enhanced protective effects against DENV infections.

AB - The heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli display adjuvant effects to coadministered antigens, leading to enhanced production of serum antibodies. Despite extensive knowledge of the adjuvant properties of LT derivatives, including in vitro-generated non-toxic mutant forms, little is known about the capacity of these adjuvants to modulate the epitope specificity of antibodies directed against antigens. This study characterizes the role of LT and its non-toxic B subunit (LTB) in the modulation of antibody responses to a coadministered antigen, the dengue virus (DENV) envelope glycoprotein domain III (EDIII), which binds to surface receptors and mediates virus entry into host cells. In contrast to non-adjuvanted or alum-adjuvanted formulations, antibodies induced in mice immunized with LT or LTB showed enhanced virus-neutralization effects that were not ascribed to a subclass shift or antigen affinity. Nonetheless, immunosignature analyses revealed that purified LT-adjuvanted EDIII-specific antibodies display distinct epitope-binding patterns with regard to antibodies raised in mice immunized with EDIII or the alum-adjuvanted vaccine. Notably, the analyses led to the identification of a specific EDIII epitope located in the EF to FG loop, which is involved in the entry of DENV into eukaryotic cells. The present results demonstrate that LT and LTB modulate the epitope specificity of antibodies generated after immunization with coadministered antigens that, in the case of EDIII, was associated with the induction of neutralizing antibody responses. These results open perspectives for the more rational development of vaccines with enhanced protective effects against DENV infections.

KW - Adjuvants

KW - Antibodies

KW - Dengue virus

KW - Envelope protein

KW - Heat-labile toxins

KW - Immunosignature

KW - Labile toxins

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=85029816498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029816498&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2017.01175

DO - 10.3389/fimmu.2017.01175

M3 - Article

AN - SCOPUS:85029816498

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - SEP

M1 - 1175

ER -